- Home
- OLN vs RLAY Comparison
OLN vs RLAY Comparison
Compare OLN & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | OLN | RLAY |
|---|---|---|
| Founded | 1892 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.7B |
| IPO Year | 1994 | 2020 |
Fundamental Metrics
Financial Performance| Metric | OLN | RLAY |
|---|---|---|
| Price | $28.66 | $13.01 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 10 |
| Target Price | ★ $25.23 | $19.50 |
| AVG Volume (30 Days) | 2.1M | ★ 3.3M |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.92% | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $6,780,800,000.00 | $15,355,000.00 |
| Revenue This Year | $2.57 | N/A |
| Revenue Next Year | $3.51 | $324.03 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | 3.68 | ★ 53.44 |
| 52 Week Low | $18.08 | $2.71 |
| 52 Week High | $30.46 | $17.32 |
Technical Indicators
Market Signals| Indicator | OLN | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 57.74 | 46.86 |
| Support Level | $22.82 | $6.67 |
| Resistance Level | $30.46 | $17.32 |
| Average True Range (ATR) | 1.14 | 1.08 |
| MACD | 0.05 | -0.53 |
| Stochastic Oscillator | 88.55 | 23.61 |
Price Performance
Historical ComparisonAbout OLN Olin Corporation
Olin Corp manufactures and sells a variety of chemicals and chemical-based products. The company organizes itself into three segments based on the product type. The Chlor alkali products and Vinyls segment, which generates the majority of revenue, sells chlorine and caustic soda, which are used in a variety of industries including cosmetics, textiles, crop protection, and fire protection products. The Epoxy segment sells epoxy resins used in paints and coatings. The Winchester segment sells sporting ammunition and ammunition accessories under the Winchester brand. The majority of revenue comes from the United States.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.